[1]
S. Sayar, “Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection”, Turkish Journal of Gastroenterology, vol. 31, no. 7, pp. 522–528, Jan. 2020.